Private placement of 25,191,473 shares of Class A common stock at $1.89 per share under the Cambridge Subscription Agreement
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Private placement of 25,191,473 shares of Class A common stock at $1.89 per share under the Cambridge Subscription Agreement
Cambridge Nominating Agreement giving Cambridge the right to designate one Board nominee, held by Dr. Soon-Shiong
Convertible promissory note combining Tranche 1 and Tranche 2 December 2023 notes, Term SOFR plus 8.0%, maturing December 31, 2027
Convertible promissory note at Term SOFR plus 8.0%, due September 11, 2026, later converted into common stock
Promissory note at Term SOFR plus 8.0%, later extended and converted into common stock
Promissory note with up to three $10.0 million advances at Term SOFR plus 8.0%
Amended and restated shared services agreement under which NantWorks provides support services at cost plus allocations
Facility license agreement with NantWorks for the Culver City office, laboratory and cGMP manufacturing facility
Operating leases of certain assets with entities controlled by NantWorks
Multiple agreements with the Clinic to conduct clinical trials and provide transition services for product candidates
Loading...